Rgenix's Series B Round

Rgenix raised a round of funding on June 15, 2016.

Rgenix is a privately-held cancer therapeutics company focused on the discovery and development of cancer drugs that target key pathways in cancer progression. Using a miRNA based target discovery pla…

Articles about Rgenix's Series B Round: